DataMEDS AI Inc.
MEDS | NASDAQ
$1.74
-$0.18 (-9.38%)
Nov 2, 2026, 2:33 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.78M | 1.56M | 1.67M | 3.01M | 7.79M | 10.86M | 12.41M | 5.67M | 10.44M | 7.94M | 34.37M | n/a | n/a |
Cost of Revenue | 1.95M | 1.39M | 11.93M | 2.78M | 7.29M | 10.17M | 11.81M | 5.62M | 9.04M | 7.12M | 31.6M | n/a | n/a |
Gross Profit | -174.39K | 170.22K | -10.26M | 231.01K | 505.75K | 692.64K | 601.44K | 53.82K | 1.4M | 820.11K | 2.77M | n/a | n/a |
Operating Income | -7.35M | -6.02M | -12.8M | -31.55M | -5.5M | -31.35M | -3.75M | -1.74M | -2.29M | -1.49M | -10.32M | -903.31K | -428.76K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -18.36M | -7.74M | -27.85M | -34.32M | -6.67M | -32.43M | -4.33M | -1.87M | -2.38M | -1.77M | -11.8M | -903.31K | -428.76K |
Net Income | -18.36M | -7.74M | -27.85M | -34.32M | -6.67M | -32.43M | -4.33M | -1.87M | -2.38M | -1.77M | -11.8M | -903.31K | -428.76K |
Selling & General & Admin | 7.17M | 5.83M | 4.14M | 30.98M | 5.2M | 31.24M | 4.35M | 1.8M | 1.83M | 1.84M | 8.3M | 903.31K | 428.76K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 356.82K | -1.61M | 802.79K | 802.8K | 802.87K | n/a | n/a | 1.85M | 467.3K | 4.79M | n/a | n/a |
Operating Expenses | 7.17M | 6.19M | 2.53M | 31.78M | 6.01M | 32.04M | 4.35M | 1.8M | 3.68M | 2.31M | 13.09M | 903.31K | 428.76K |
Interest Expense | 1.56M | 2.07M | 875.72K | 1.43M | 1.18M | 1.09M | 689.19K | 137.61K | 518.26K | 299.03K | 1.58M | n/a | n/a |
Selling & Marketing Expenses | 113.99K | 960K | 12.17K | 803.75K | 343.38K | 65.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.12M | 7.58M | 14.47M | 34.56M | 13.29M | 42.21M | 16.16M | 7.42M | 12.72M | 9.42M | 44.69M | 903.31K | 428.76K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.57M | 2.09M | 1.42M | 1.49M | 1.24M | 1.04M | 1.04M | 1.04M | 1.04M | 977.29K | 935.84K | 1.04M | 1.04M |
Shares Outstanding (Diluted) | 2.57M | 2.09M | 1.42M | 1.49M | 1.24M | 1.04M | 1.04M | 1.04M | 1.04M | 977.29K | 935.84K | 1.04M | 1.04M |
EPS (Basic) | -7.13 | -3.50 | -13.50 | -23 | -5.50 | -31 | -4.17 | -1.80 | -0.56 | -1.81 | -12.60 | -0.87 | -0.41 |
EPS (Diluted) | -7.13 | -3.50 | -13.50 | -23 | -5.50 | -31 | -4.17 | -1.80 | -0.56 | -1.81 | -12.60 | -0.87 | -0.41 |
EBITDA | -6.99M | -5.31M | -12.02M | -32.09M | -4.69M | -30.53M | -3.1M | -1.29M | -11.89K | -1.01M | -5.43M | -903.31K | -428.76K |
EBIT | -7.35M | -5.67M | -12.82M | -32.89M | -5.49M | -31.34M | -3.75M | -1.74M | -1.87M | -1.48M | -10.22M | -903.31K | -428.76K |
Depreciation & Amortization | 356.6K | 356.82K | 802.6K | 802.8K | 802.8K | 802.87K | 647.24K | 454.63K | 1.85M | 467.3K | 4.79M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MEDS